About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...

New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?

An analysis of more than 250,000 older adults diagnosed with metastatic non-small cell lung cancer showed only about half ...

The annual cancer statistics report from the National Cancer Institute (NCI) — which was published in the journal Cancer on Monday, April 21 — shows some signs of progress in America’s fight against ...

MADISON, Wis. (WSAW) - The Wisconsin Cancer Collaborative has published its most recent data about the number of lung cancer cases in Wisconsin. It found lung cancer incidence and mortality in ...

Candel Therapeutics has identified a subpopulation of lung cancer patients living longest on its oncolytic virus, leading the biotech to narrow its focus as it heads towards a potentially ...

Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena. The ALKOVE ...

A new University of Kentucky Markey Cancer Center study published in JAMA Internal Medicine found that lung cancer screening ...

PD-L1xVEGF-A bispecific antibody pumitamig (BNT327/BMS986545) plus chemotherapy continues to show encouraging antitumor activity in patients with extensive-stage small cell lung cancer (”ES-SCLC”), ...

Silexion Therapeutics reports positive preclinical results for SIL204 in lung cancer, advancing dual-route administration and preparing for upcoming clinical trials. Silexion Therapeutics Corp.